Adial Pharmaceuticals, Inc · NASDAQ:ADIL
Coastlands Capital LP reported a 14.22% stake in Adial Pharmaceuticals, Inc (Schedule 13G/A)
Event Jun 24, 2026 · Filed Jul 1, 2026
Coastlands Capital LP reported a 14.22% stake in Adial Pharmaceuticals, Inc, 373,322 shares, as a passive investor on Jun 24, 2026. Filed Jul 1, 2026 (Schedule 13G/A).
- Stake
- 14.22%
- Shares
- 373,322
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Coastlands Capital LP | 14.22% | 373,322 |
| Coastlands Capital Partners LP | 14.22% | 373,322 |
| Coastlands Capital GP LLC | 14.22% | 373,322 |
| Coastlands Capital LLC | 14.22% | 373,322 |
| Matthew D. Perry | 14.22% | 373,322 |
Source
Related
- Adial Pharmaceuticals, Inc
- Coastlands Capital LP
- Adial Pharmaceuticals, Inc shareholders
- Schedule 13G · Coastlands Capital LP · Jun 24, 2026
- Form 4 · Coastlands Capital LP · Jul 16, 2026
- Form 4 · Coastlands Capital LP · Jul 13, 2026
- Form 4 · Coastlands Capital LP · Jul 1, 2026
- Form 4 · Davidson Matt · Jun 16, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026